TABLE I.
Results (three-tests)a | Post-test probability of BeS (PTP-BeS)b
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Population prevalence
| ||||||||||
1% | 2% | 3% | 4% | 5% | 6% | 7% | 8% | 9% | 10% | |
3 AB | 0.999 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
2 AB,1BL | 0.996 | 0.998 | 0.999 | 0.999 | 0.999 | 0.999 | 0.999 | 1.000 | 1.000 | 1.000 |
1AB, 2 BL | 0.972 | 0.986 | 0.991 | 0.993 | 0.995 | 0.996 | 0.996 | 0.997 | 0.997 | 0.997 |
2 AB,1NL | 0.896 | 0.946 | 0.964 | 0.973 | 0.978 | 0.982 | 0.985 | 0.987 | 0.988 | 0.989 |
3 BL | 0.837 | 0.912 | 0.940 | 0.955 | 0.964 | 0.970 | 0.974 | 0.978 | 0.980 | 0.983 |
1AB,1BL,1NL | 0.557 | 0.717 | 0.794 | 0.838 | 0.867 | 0.888 | 0.903 | 0.915 | 0.925 | 0.932 |
Single test first round, split sample second round if AB or BL.
If PTPBeS ≥ 0.9995, then PTPBeS ~1.000.